The treatment of diffuse sclerosing osteomyelitis with oral bisphosphonates

Publisher： John Wiley & Sons Inc

E-ISSN： 1752-248x|11|1|69-78

ISSN： 1752-2471

Source： ORAL SURGERY, Vol.11, Iss.1, 2018-02, pp. : 69-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calvarial Sclerosing Osteomyelitis

By  

Pediatric Neurosurgery, Vol. 36, Iss. 3, 2002-03 ,pp. : 128-132

Karger

Access to resources Recommend Favorite

Bisphosphonates for osteoporosis prevention and treatment

By Jarvis Courtney   Morin Anna   Lynch Ann  

Clinical Review in Bone and Mineral Metabolism, Vol. 3, Iss. 1, 2005-03 ,pp. : 3-18

Humana Press, Inc

Access to resources Recommend Favorite

Injectable bisphosphonates for the treatment of osteoporosis

By Reginster Jean-Yves   Burlet Nansa   Close Pierre   Bruyere Olivier  

Women's Health, Vol. 3, Iss. 6, 2007-11 ,pp. : 719-723

Future Medicine

Access to resources Recommend Favorite

Bisphosphonates in the Treatment of Thalassemia-Induced Osteoporosis

By Morabito N.   Lasco A.   Gaudio A.   Crisafulli A.   Di Pietro C.   Meo A.   Frisina N.  

Osteoporosis International, Vol. 13, Iss. 8, 2002-08 ,pp. : 644-649

Springer Publishing Company

Access to resources Recommend Favorite

Linezolid in the Treatment of Osteomyelitis: Results of Compassionate Use Experience

By Rayner C.   Baddour L.   Birmingham M.   Norden C.   Meagher A.   Schentag J.  

Infection, Vol. 32, Iss. 1, 2004-02 ,pp. : 8-14

Springer Publishing Company

Access to resources Recommend Favorite